3D Bioprinting of Functional Skin Substitutes: From Current Achievements to Future Goals
dc.contributor.author | Manita, Paula Gabriela | |
dc.contributor.author | García Orúe, Itxaso | |
dc.contributor.author | Santos Vizcaíno, Edorta | |
dc.contributor.author | Hernández Martín, Rosa María | |
dc.contributor.author | Igartua Olaechea, Manuela | |
dc.date.accessioned | 2021-04-28T08:45:42Z | |
dc.date.available | 2021-04-28T08:45:42Z | |
dc.date.issued | 2021-04-14 | |
dc.identifier.citation | Pharmaceuticals 14(4) : (2021) // Article ID 362 | es_ES |
dc.identifier.issn | 1424-8247 | |
dc.identifier.uri | http://hdl.handle.net/10810/51219 | |
dc.description.abstract | The aim of this review is to present 3D bioprinting of skin substitutes as an efficient approach of managing skin injuries. From a clinical point of view, classic treatments only provide physical protection from the environment, and existing engineered scaffolds, albeit acting as a physical support for cells, fail to overcome needs, such as neovascularisation. In the present work, the basic principles of bioprinting, together with the most popular approaches and choices of biomaterials for 3D-printed skin construct production, are explained, as well as the main advantages over other production methods. Moreover, the development of this technology is described in a chronological manner through examples of relevant experimental work in the last two decades: from the pioneers Lee et al. to the latest advances and different innovative strategies carried out lately to overcome the well-known challenges in tissue engineering of skin. In general, this technology has a huge potential to offer, although a multidisciplinary effort is required to optimise designs, biomaterials and production processes. | es_ES |
dc.description.sponsorship | This research was funded by the Spanish Ministry of Economy and Competitiveness through the “RETOS” Program (NANOGROW project, RTC-2017-6696-1) and by the Basque Government (Grupos Consolidados, IT 907-16) and through the PhD grant conceded to Paula Gabriela Maniţă (PRE_2020_2_0261). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | MDPI | es_ES |
dc.relation | info:eu-repo/grantAgreement/MINECO/RTC-2017-6696-1 | es_ES |
dc.rights | info:eu-repo/semantics/openAccess | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | |
dc.subject | skin bioprinting | es_ES |
dc.subject | 3D bioprinting | es_ES |
dc.subject | wounds | es_ES |
dc.subject | bioinks | es_ES |
dc.subject | tissue engineering | es_ES |
dc.title | 3D Bioprinting of Functional Skin Substitutes: From Current Achievements to Future Goals | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.date.updated | 2021-04-23T13:31:45Z | |
dc.rights.holder | 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). | es_ES |
dc.relation.publisherversion | https://www.mdpi.com/1424-8247/14/4/362/htm | es_ES |
dc.identifier.doi | 10.3390/ph14040362 | |
dc.departamentoes | Farmacia y ciencias de los alimentos | |
dc.departamentoeu | Farmazia eta elikagaien zientziak |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's license is described as 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).